SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genaissance Pharmaceuticals (GNSC)
An SI Board Since September 2000
Posts SubjectMarks Bans Symbol
183 6 0 GNSC
Emcee:  Jim Oravetz Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
33SemiOT:06:55 ET Myriad Genetics (MYGN) 47.53: Company and Pharmacia (PHA) initiaJim Oravetz-10/30/2001
32Genaissance Pharmaceuticals Reports Third Quarter and Nine Month Results NEW HAnigel bates-10/24/2001
31Genaissance Pharmaceuticals Files Universal Shelf Registration Statement NEW HAJim Oravetz-10/19/2001
30Genaissance Pharmaceuticals Initiates Second Personalized Medicine Clinical Studnigel bates-10/18/2001
29Some validation at last - Genaissance Pharmaceuticals Signs Pharmacogenomics Agnigel bates-10/9/2001
28Regarding a "Haplotype map" of human genome: sciencedaily.comZirdu-10/4/2001
27...Now Genaissance Pharmaceuticals is taking the research to the next level. In Jim Oravetz-9/27/2001
26Genaissance gets some air time on NPR Morning edition today. I can not find the Jim Oravetz-8/30/2001
25Designer Drugs:What's best for patients isn't always what's best forJim Oravetz-8/23/2001
24Genaissance Pharma 2Q Losses 58c A SHr Vs $3.57 Genaissance Pharmaceuticals IncJim Oravetz-7/25/2001
23Genaissance Pharmaceuticals Completes Enrollment Goal in Largest Personalized Menigel bates-7/19/2001
22Genaissance Publishes Research Outlining Variations in 313 Genes By GEETA ANAND Jim Oravetz-7/13/2001
21Big Drug Companies Try to Delay 'Personalized' Medicine Regimens By GEETJim Oravetz-6/18/2001
20Old News: San Francisco and New Haven - Sept. 21, 2000 - Telik, Inc. (Nasdaq: TEJim Oravetz-4/24/2001
19Jim... I appreciated the link. Now I wish that I understood more of it. One cBob Trocchi-3/27/2001
18Hello Jim, You are right that was an interesting article. Hopefully with these jeanmarcel-3/26/2001
17Follow this link has a very interesting article on Pharmacogenomics in the HarvaJim Oravetz-3/26/2001
16Hello, My name is Jean-Marcel Staley and I just recently received some news abojeanmarcel-3/24/2001
15Bob, thanks for joining in. Yes, not much action here. There are others that hJim Oravetz-3/9/2001
14Jim... Don't be too shocked to see someone responding to you! You seem veryBob Trocchi-3/9/2001
13Genaissance Pharma 4Q Losses 50c A Shr Vs $1.42 Dow Jones Newswires GenaissanceJim Oravetz-2/22/2001
12Biotechs Face New Year Hangover From IPO Overhang By Dane Hamilton Staff RepoJim Oravetz-1/11/2001
11Genaissance Pharmaceuticals Inc. (GNSC) signed a multi-year agreement with JohnsJim Oravetz-11/27/2000
10Semi-OT: New Real-Time PCR System for Exceptionally High-Throughput Demands of tJim Oravetz-11/21/2000
9Call Reply comments: Suggested to look for company recent S-1. CEO talked aboutJim Oravetz-11/3/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News